Colo. Federal Judge Allows Beovu Warning, Fraud Claims to Proceed



DOCUMENTS
  • Order


BOULDER, Colo. — A federal judge has refused to dismiss an action in which a Colorado woman alleges Novartis Pharmaceuticals Corp.’s eye disease drug Beovu caused her to develop retinal vascular occlusion, ruling that the claims are not preempted at this stage in the litigation.

In a Dec. 6 order, Judge Raymond P. Moore of the U.S. District Court for the District of Colorado found the plaintiff pointed to possible “newly discovered evidence” in the form of adverse event reports that would have supported a label change via the FDA’s Changes Being Effected process before she received her injection.

Normalee …






UPCOMING CONFERENCES




HarrisMartin's MDL Conference: Managing Mass Torts, Status of Key Litigations and Lessons Learned

March 29, 2023 - Tucson, AZ
Omni Tucson National Resort

MORE DETAILS



HarrisMartin's New Jersey Asbestos Litigation Conference

March 03, 2023 - New Brunswick, NJ
Hyatt Regency New Brunswick

MORE DETAILS